<DOC>
	<DOC>NCT01155830</DOC>
	<brief_summary>This study proposes to quantify inflammatory cytokine profiles in three neonatal disease states, namely, neonatal sepsis, infants with a congenital diaphragmatic hernia defect, and infants suffering cardiopulmonary failure significant enough to require heart/lung bypass treatment with extracorporeal membrane oxygenation (ECMO).</brief_summary>
	<brief_title>Inflammatory Cytokine Quantification in Infants</brief_title>
	<detailed_description>Very small blood samples (500 microliters) will be collected serially in these patients and analyzed with current cytokine array technology. A convenience sample of 60 patients, 20 with each of these diagnoses, will be collected over a 2 year period. These data will provide baseline information for possible therapeutic intervention with agents that enhance or suppress specific mediators, or adjust mediator balance to promote patient healing.</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Hernia, Diaphragmatic</mesh_term>
	<mesh_term>Hernias, Diaphragmatic, Congenital</mesh_term>
	<criteria>Gestational age â‰¥ 34 weeks, Indwelling vascular catheter available for blood draws, Documented culture positive sepsis on vasopressors , and/or Congenital diaphragmatic hernia (CDH), and/or ECMO therapy Other major congenital anomalies Lack of parental consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Months</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>inflammatory cytokines</keyword>
	<keyword>extracorporeal membrane oxygenation</keyword>
	<keyword>ECMO</keyword>
</DOC>